Source comparison
TB-500 vs BPC-157 vs Standard Recovery — Evidence Comparison
TB-500 (Thymosin Beta-4) Actin upregulation, angiogenesis, cell migration to injury sites Case reports and veterinary trials. No Phase III human data 4–6 weeks at 2–5 mg twice weekly Strongest evidence in tendon repair; muscle recovery benefits remain extrapol
This comparison does not assign a generated winner or score.
- TB-500 (Thymosin Beta-4)
- Actin upregulation, angiogenesis, cell migration to injury sites
- Case reports and veterinary trials. No Phase III human data
- 4–6 weeks at 2–5 mg twice weekly
- Strongest evidence in tendon repair; muscle recovery benefits remain extrapolated from animal models
- BPC-157 (Body Protection Compound)
- VEGF upregulation, nitric oxide modulation, fibroblast proliferation
- Preclinical rodent studies only. Zero human trials published
- 4–8 weeks at 250–500 mcg daily
- Mechanism is plausible but entirely unvalidated in humans; claims exceed evidence
- Standard RICE Protocol
- Inflammation suppression, mechanical support, controlled loading
- Decades of clinical use with mixed outcomes in recent meta-analyses
- 72 hours acute phase, then progressive loading
- Evidence suggests early mobilisation outperforms prolonged rest for most muscle injuries
- Therapeutic Peptides (e.g., Cartalax)
- Varies by compound. Some target cellular repair pathways, others modulate inflammation
- Compound-specific; research-grade peptides with documented mechanisms available
- Protocol-dependent
- Quality matters. Peptides synthesised with exact amino-acid sequencing ensure reproducible outcomes
- The comparison reveals a pattern: the peptides with the strongest marketing presence have the weakest human evidence. TB-500's veterinary data and actin mechanism give it more biological plausibility than BPC-157, but neither compound has undergone the randomised controlled human trials required to establish efficacy claims. Standard recovery protocols remain the evidence-based baseline, with peptide interventions functioning as experimental adjuncts rather than replacements.